Immunoreactive trypsin in the blood of newborns (test for congenital cystic fibrosis)
Last reviewed: 23.04.2024
All iLive content is medically reviewed or fact checked to ensure as much factual accuracy as possible.
We have strict sourcing guidelines and only link to reputable media sites, academic research institutions and, whenever possible, medically peer reviewed studies. Note that the numbers in parentheses ([1], [2], etc.) are clickable links to these studies.
If you feel that any of our content is inaccurate, out-of-date, or otherwise questionable, please select it and press Ctrl + Enter.
Cystic fibrosis (cystic fibrosis) is a fairly common disease. Cystic fibrosis is inherited by autosomal recessive type, it is detected in 1 of 1500-2500 newborns. Due to early diagnosis and effective treatment, the disease is no longer considered to be inherent only in childhood and adolescence. With the improvement of methods of treatment and diagnosis, an increasing number of patients reach adulthood. Currently, 50% of patients survive to 25 years. The main method of early postnatal diagnosis of cystic fibrosis is the determination of the concentration of trypsin in the serum of newborns.
Reference values (norm) of concentration of immunoreactive trypsin in blood serum
|
Age |
Immunoreactive trypsin, μg / l |
|
Blood from the umbilical cord |
23.3 ± 1.9 |
|
0-6 months |
31.3 ± 5.4 |
|
6-12 months |
37.1 ± 6.9 |
|
1-3 years |
29.8 ± 1.8 |
|
3-5 years |
28.3 ± 3.2 |
|
5-7 years |
35.7 ± 3.6 |
|
7-10 years old |
34.9 ± 2.2 |
|
Adults |
33.3 ± 11.1 |
An increase in the concentration of trypsin in the blood serum of children in the first few weeks after birth indicates the presence of cystic fibrosis, and therefore the definition of this indicator is considered an effective screening method. With the progression of the disease and the development of true pancreatic insufficiency, the concentration of trypsin in the blood serum decreases.
[